ConductScience.org, home

Paper3355415

The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.

Flach AJ and 3 others. Arch Ophthalmol, 1988. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Papers, record 3355415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3355415

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
PubMed
Journal
Arch Ophthalmol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
4.59
iCite
Revised in PubMed
2019-07-04
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Flach AJA J
2Kraff MCM C
3Sanders DRD R
4Tanenbaum LL

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aqueous HumorMajor topic
Capillary PermeabilityMajor topic
Cataract ExtractionMajor topic
DexamethasoneMajor topic
EyeMajor topic
PyrrolesMajor topic
TolmetinMajor topic
TromethamineMajor topic
Adult
Drug Combinations
Female
Fluorometry
Humans
Ketorolac Tromethamine
Lenses, Intraocular
Male
Middle Aged
Photometry
Postoperative Period
Solutions

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
40007877Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, Pathogenesis, Risk Factors and Treatment.Clin Ophthalmol2025https://conductscience.org/library/papers/40007877PubMed
38283484Macular Edema Following Silicone Oil Tamponade for Retinal Detachment: A Literature Review.Cureus2023https://conductscience.org/library/papers/38283484PubMed
27801522Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27801522PubMed
24288446Inflammation and macular oedema after pars plana vitrectomy.Mediators Inflamm2013https://conductscience.org/library/papers/24288446PubMed
24227908Topical nonsteroidal anti-inflammatory drugs for macular edema.Mediators Inflamm2013https://conductscience.org/library/papers/24227908PubMed
23365785Nonsteroidal anti-inflammatory drugs for retinal disease.Int J Inflam2013https://conductscience.org/library/papers/23365785PubMed
22570544Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction.Clin Ophthalmol2012https://conductscience.org/library/papers/22570544PubMed
21750608Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery.Clin Ophthalmol2011https://conductscience.org/library/papers/21750608PubMed
19668551Diclofenac prevents temporal increase of intraocular pressure after uneventful cataract surgery with longer operation time.Clin Ophthalmol2009https://conductscience.org/library/papers/19668551PubMed
17285752Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.AAPS PharmSciTech2006https://conductscience.org/library/papers/17285752PubMed
16354013In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.AAPS PharmSciTech2005https://conductscience.org/library/papers/16354013PubMed
11820911Locally administered ocular corticosteroids: benefits and risks.Drug Saf2002https://conductscience.org/library/papers/11820911PubMed
10360304The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.Trans Am Ophthalmol Soc1998https://conductscience.org/library/papers/10360304PubMed
9290366Conventional routine clinical review may not be necessary after uncomplicated phacoemulsification.Br J Ophthalmol1997https://conductscience.org/library/papers/9290366PubMed
8703890Diffusion coefficient through the blood-aqueous barrier using a standard protocol.Br J Ophthalmol1996https://conductscience.org/library/papers/8703890PubMed
8695573The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.Br J Ophthalmol1996https://conductscience.org/library/papers/8695573PubMed
2178916Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.Drugs1990https://conductscience.org/library/papers/2178916PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3355415

GET https://conductscience.org/api/papers/v1/3355415/authors